Agilent and Ubix Therapeutics Collaborate to Drive Breakthrough Cancer Research in South Korea

Agilent Technologies and Ubix Therapeutics Forge Strategic Collaboration to Propel Advanced Cancer Research in South Korea In a significant move to accelerate innovation in cancer therapeutics, Agilent Technologies has officially entered into a Memorandum of Understanding (MOU) with Ubix Therapeutics,…